Se-Jin Park
Director of Finance/CFO at LIGACHEM BIOSCIENCES INC.
Net worth: 9 M $ as of 30/04/2024
Profile
Se-Jin Park is currently the Director at LegoChem Pharma, Inc. He is also a Non-Executive Director at BASKHANBIOPharma, Inc. and the Chief Operating & Financial Officer at LigaChem Biosciences, Inc. Previously, he worked as a Team Leader-Visual Materials at LG Chem Ltd.
from 2003 to 2006.
Dr. Park completed his undergraduate degree at Korea University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/04/2024 | 181,528 ( 0.50% ) | 9 M $ | 30/04/2024 |
Se-Jin Park active positions
| Companies | Position | Start |
|---|---|---|
| LIGACHEM BIOSCIENCES INC. | Director of Finance/CFO | 15/09/2011 |
| BASKHANBIO PHARMA INC. | Director/Board Member | 01/01/2016 |
LegoChem Pharma, Inc.
 LegoChem Pharma, Inc. Pharmaceuticals: MajorHealth Technology LegoChem Pharma, Inc. manufactures pharmaceutical products. Its products include generic and prescription drugs, ophthalmic solvents, and ophthalmic surgical supplies. The company was founded in 1968 and is headquartered in Seoul, South Korea. | Director/Board Member | - |
Former positions of Se-Jin Park
| Companies | Position | End |
|---|---|---|
| LG CHEM, LTD. | Corporate Officer/Principal | 01/06/2006 |
Training of Se-Jin Park
| Korea University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| LIGACHEM BIOSCIENCES INC. | Health Technology |
| LG CHEM, LTD. | Process Industries |
| BASKHANBIO PHARMA INC. | Health Technology |
| Private companies | 1 |
|---|---|
LegoChem Pharma, Inc.
LegoChem Pharma, Inc. Pharmaceuticals: MajorHealth Technology LegoChem Pharma, Inc. manufactures pharmaceutical products. Its products include generic and prescription drugs, ophthalmic solvents, and ophthalmic surgical supplies. The company was founded in 1968 and is headquartered in Seoul, South Korea. | Health Technology |
- Stock Market
- Insiders
- Se-Jin Park
